Magseed features on BBC 2’s Trust Me I’m A Doctor

18 January 2018

In its recent programme, the topical health show features Magseed, a technology from UCLB spinout Endomag, which is aiding doctors in the treatment of breast cancer patients.

Gabriel Weston follows a patient undergoing breast cancer treatment at the Royal Marsden Hospital. She discovers how Endomag’s Magseed technology is helping surgeons to precisely remove breast tumours in patients.

The minimally invasive breast marker is smaller than a grain of rice and allows radiologists to mark the tumour site, up to 30 days before surgery.

See Wednesday night’s show here

About UCLB

UCL Business PLC (UCLB) is a leading technology transfer company that supports and commercialises research and innovations arising from UCL, one of the UK’s top research-led universities. UCLB has a successful track record and a strong reputation for identifying and protecting promising new technologies and innovations from UCL academics. UCLB has a strong track record in commercialising medical technologies and provides technology transfer services to UCL’s associated hospitals; University College London Hospitals, Moorfields Eye Hospital, Great Ormond Street Hospital for Children and the Royal Free London Hospital. It invests directly in development projects to maximise the potential of the research and manages the commercialisation process of technologies from laboratory to market.

For further information, please visit: www.uclb.com

About Endomag
Endomag is dedicated to improving the global standard cancer care for everyone, everywhere, by developing a new, effective clinical platform that uses safe magnetic fields to power diagnostic and therapeutic devices.

Endomag’s first approved products are the Sentimag® and Sienna+®, CE-approved for marketing and sales in Europe, and TGA-approved for Australasia.  Sienna+® is a magnetic tracer injected into the body and the Sentimag® is used to track its presence, locating lymph nodes as part of a sentinel lymph node biopsy (SLNB) procedure.

By avoiding the need for traditional radioactive isotopes in sentinel lymph node biopsy, Sentimag® and Sienna+® improve workflow and lower costs, enhance patient comfort and quality of life, and provide a better standard of care available to everyone, everywhere.

For further information, please visit: www.endomag.com

2018-01-18T11:32:42+00:00